The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Study Investigators (U01)

The summary for the The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Study Investigators (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Study Investigators (U01): Purpose. The purpose of this funding opportunity announcement (FOA) is to provide support for the most competitive existing eMERGE phase I sites and new sites with existing biorepositories and genome-wide genotyping data to incorporate state-of-the-art methods generated in eMERGE Phase I into clinical research and ongoing clinical care in a Phase II eMERGE expansion. Mechanism of Support. This FOA will utilize the U01 Cooperative Agreement award mechanism. Funds Available and Anticipated Number of Awards. The total amount to be awarded over the 4-year period of this FOA is approximately $22 million. It is anticipated that up to 8 awards will be made under this FOA.

Federal Grant Title:	The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Study Investigators (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HG-10-009
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.172
CFDA Descriptions:	Human Genome Research
Current Application Deadline:	Nov 17, 2010
Original Application Deadline:	Nov 17, 2010
Posted Date:	Jul 15, 2010
Creation Date:	Jul 21, 2010
Archive Date:	Dec 18, 2010
Total Program Funding:	$22,000,000
Maximum Federal Grant Award:	$500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required); • Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required); • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed); • Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed); • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Opti...; • Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Opti...; • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required); • Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans...; • Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)